doi: Ghusn W, De la Rosa A, Sacoto D, et al
Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide
Semaglutide GLP-1 is a GLP-1 receptor agonist, which means it mimics the GLP-1 hormone
Muscle loss drops your metabolic rate, which makes fat loss harder, which makes the scale stall, which makes you think Retatrutide stopped working
Dec 14, 2023 2 min read Semaglutide, marketed as Ozempic for diabetes management and Wegovy for weight loss, has seen a dramatic increase in misuse cases over the past year
Marston et al., 2019)